In connection with the CC, while I am not going to guess what may or may not be said specifically, I think it must absolutely focus on 2 main things, which are the BLA and what happened to the deal/what the current status of a new deal is.

As for cancer and NASH updates, those are, to me, tangential and will be nice add-ons to what we really need to hear about, based on NP and his talk of when the BLA would be filed and how close we were/are to non-dilutive funding.

I will not be upset to find that CYDY walked away from a bad deal or that the potential partner did not have enough money to make a reasonable offer for the potential of Leronlimab, but I do want a concrete update as to the status of things.